The Niche
Stem-cell company Novocell brings in genomics CEO
Novocell, a San Diego company developing stem-cell technology for treating diabetes, has named its new CEO. John West has previously held management posts at Applied Biosystems. He was CEO of DNA sequencing company Solexa, until he sold it to Illumina for $600 million. (See the Novocell’s announcement and the San Diego Tribune article.